Clinical Trial Update: Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 efficacy study evaluating CD34-positive stem cell therapy in chronic stroke patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Middle Cerebral Artery Infarction
• Stroke

Drugs mentioned

• CD34+ stem cell therapy (CD34-positive stem cells)

Snippet

Sponsor: China Medical University Hospital | Conditions: Stroke, Middle Cerebral Artery Infarction | Phase 2 | Status: COMPLETED